Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.965 EUR | +0.42% | -9.14% | -71.97% |
05/09 | Evotec, X-Chem to Collaborate on Early-Stage Drug Discovery | MT |
05/09 | Evotec SE and X-Chem Inc. Collaborates to Accelerate Early-Stage Drug Discovery | CI |
Group Evotec SE: Relations chart
Private companies belonging to the same group as EVOTEC SE
Company | Manager |
---|---|
Evotec (France) SAS
Evotec (France) SAS Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (France) SAS is a French company that engages in research and development of physical and natural sciences. The company is based in Toulouse, France. The company was founded in 2014. Pierre Cooremans has been the CEO of the company since 2019. | Pierre Cooremans |
Evotec (UK) Ltd.
Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The company is based in Abingdon, UK and was founded in 1991. | - |
Evotec International GmbH
Evotec International GmbH Miscellaneous Commercial ServicesCommercial Services Evotec International GmbH develops and provides drugs for the treatment of CNS disorders. It focuses on Alzheimer's disease and other neurological disorders. The company was founded in 1999 and is headquartered in Hamburg, Germany. | Matthias Evers |
Aptuit (Verona) Srl | Ciriaco Maraschiello |
MarketScreener is also available in this country: United States.
Switch edition